Sarah McBride / Bloomberg:
Colorado-based Enveda, which uses AI to find drug candidates, raised $130M, after raising $55M in June, and launches a clinical trial for an oral eczema drug — AI has so far failed to transform health care, but investors are betting on its potential. — Enveda Therapeutics Inc. …
No comment yet, add your voice below!